BioPharm International® Interview Series | Part 4
In a recent BioPharm International interview, ConcertAI CEO Eron Kelly and Dr. Shaalan Beg, Chief Medical Officer, Oncology, discuss how artificial intelligence can help oncology practices strengthen patient care and clinical research. They explore how AI can curate and synthesize vast amounts of information across the CancerLinQ network, helping physicians access relevant insights at the point of care. The conversation also highlights how technology can support clinical trial identification and enrollment, real-world evidence generation, and quality improvement initiatives—while empowering physicians to make better-informed decisions.